Parexel Opens Peru Office

Parexel International has opened an office in Lima, Peru to provide regulatory consulting and clinical research capabilities. With the addition of the Peru office, Parexel now has locations throughout five important biopharmaceutical centers in Latin America, which also include Argentina, Brazil, Chile, and Mexico. This expansion further strengthens the company’s position as one of the largest biopharmaceutical services providers in this emerging region for clinical development, according to a company statement.

“Parexel has had a presence in Latin America since 1997, and a long-term commitment to providing clients with high quality services in the region,” said Josef H. von Rickenbach, chairman and chief executive officer of Parexel. “Due to the increasing globalization of clinical research, client demand for our capabilities in Latin America has been steadily increasing, and over the last seven years Parexel has experienced double-digit growth in the region. Peru is a key growing market in Latin America, with approximately 28 million people. The opening of our Peru office marks a significant opportunity for clients to further expand their clinical development programs throughout Latin America.”

Capabilities provided by Parexel’s Latin American locations include regulatory advice for clinical development, as well as a broad range of services including project management, site management, data management, medical affairs, biostatistics, and bioanalysis for the conduct of Phase II-IV studies.

For breaking news from this year’s AAPS conference, visit our Live from AAPS site!